These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 12684401
21. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data. Kantarjian HM, O'Brien S, Cortes J, Giles FJ, Rios MB, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Verstovsek S, Wierda W, Keating M, Talpaz M. Cancer; 2003 Dec 15; 98(12):2636-42. PubMed ID: 14669283 [Abstract] [Full Text] [Related]
29. [Bone marrow morphologic features in patients treated with imatinib for Philadelphia chromosome positive chronic myeloid leukemia]. Jiang Q, Chen SS, Jiang B, Jiang H, Shi HL, Lu Y, Lu DP. Zhonghua Xue Ye Xue Za Zhi; 2004 Mar 15; 25(3):158-62. PubMed ID: 15182585 [Abstract] [Full Text] [Related]
31. [The prognostic implications of secondary chromosomal aberrations in Philadelphia chromosome-positive chronic myeloid leukemia patients after imatinib mesylate treatment]. Zhang Y, Jiang Q, Qiu JY, Chen SS, Jiang B, Huang XJ. Zhonghua Nei Ke Za Zhi; 2007 Aug 15; 46(8):648-50. PubMed ID: 17967235 [Abstract] [Full Text] [Related]
32. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]. Liu XL, Zhou SY, Du QF, Zheng WY, Zhang S, Song LL, Xu B, Liu QF, Meng FY. Ai Zheng; 2004 Apr 15; 23(4):421-5. PubMed ID: 15087031 [Abstract] [Full Text] [Related]
34. Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantation. Medeiros BC, Chun K, Kamel-Reid S, Lipton J. Am J Hematol; 2007 Aug 15; 82(8):758-60. PubMed ID: 17301975 [Abstract] [Full Text] [Related]
35. Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients. Cervantes F, Hernández-Boluda JC, Steegmann JL, Conde E, Alvarez-Larrán A, López-Jiménez J, Osorio S, Villalón L, Camós M, García-Conde J, Odriozola J. Haematologica; 2003 Oct 15; 88(10):1117-22. PubMed ID: 14555307 [Abstract] [Full Text] [Related]
38. Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country. Aziz Z, Iqbal J, Akram M, Saeed S. Cancer; 2007 Mar 15; 109(6):1138-45. PubMed ID: 17315159 [Abstract] [Full Text] [Related]